Long term toxicity of intracranial germ cell tumor treatment in adolescents and young adults.
Jordan WongKaren GoddardNormand LaperriereJennifer DangEric BouffetUte BartelsDavid HodgsonScott TyldesleyJuliette HukinSylvia ChengPhilippe L BedardAndrea C LoPublished in: Journal of neuro-oncology (2020)
A significant proportion of AYAs treated for IGCTs experience late effects from treatment, including neurocognitive impairment, ototoxicity, and hormone deficiency. Suprasellar/hypothalamic tumor location and cisplatin were associated with a higher risk of treatment-induced hormone deficiency and ototoxicity, respectively.